Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Govt Recovers Just...

    Govt Recovers Just 7.8% of Rs 4,928 cr Drug Overcharging Fine

    Written by savita thakur thakur Published On 2016-05-11T12:26:49+05:30  |  Updated On 11 May 2016 12:26 PM IST
    Govt Recovers Just 7.8% of Rs 4,928 cr Drug Overcharging Fine

    New Delhi : The government has been able to recover just Rs 386.07 crore as fine, a mere 7.83 per cent of the total Rs 4,928.09 crore which has been slapped on drug companies for overcharging.


    "As on March 31, 2016, the National Pharmaceutical Pricing Authority (NPPA) has recovered Rs 386.07 crore against total demanded amount of Rs 4,928.09 crore, which is about 7.83 per cent," Minister of State for Chemicals and Fertilisers Hansraj Gangaram Ahir said in a written reply to the Lok Sabha.


    Giving details of the unrecovered amount, the minister said cases under litigation currently amounted to Rs 3,701.21 crore while recovery cases pending with collectors stood at Rs 72.26 crore. Besides, Rs 5.41 crore are under BIFR/official liquidator.


    Ahir said action for recovery of the overcharged amount is taken as per the provisions of Drugs (Prices Control) Order, 1995 and DPCO, 2013.


    "However, in some cases, the demands raised for overcharging have been challenged in courts. NPPA is actively pursuing these court cases," he added.


    If the company concerned does not deposit the amount of demand, the matter is referred to the respective collector for recovery, he said.


    "The cases referred to collectors are also followed up on a regular basis by issuing reminders.

    BIFRDPCOdrug overchargingDrug Prices Control OrderFertilisers Hansraj Gangaram AhirfineNational Pharmaceutical Pricing AuthorityNPPAovercharging or drugs
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok